Oliver Witzke - Infectious Diseases

Author Information

Oliver Witzke is affiliated with the Department of Infectious Diseases at the West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, in Germany. His expertise is reflected in his extensive research, particularly in the field of infectious diseases, focusing on responses to viral infections and the management of related conditions in vulnerable patient populations.

Research Contributions

Oliver Witzke has made significant contributions to the understanding of immune responses in various patient populations, particularly those who are immunocompromised. His research encompasses the examination of B and T cell responses in kidney transplant patients, the decline of humoral responses in hemodialysis patients after vaccination, and the management of COVID-19 in elderly, immunocompromised, or diabetic patients. Additionally, he has explored the impact of COVID-19 on the fungal gut microbiome and investigated susceptibility loci for severe COVID-19 through GWAS analysis. His work is crucial in improving clinical outcomes and vaccine strategies for at-risk groups.

Aliases

Oliver Witzke is also known by aliases such as O Witzke and O. Witzke. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	8707
H-index	48
Paper Count	420

Publications:

Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients

DOI: 10.1016/j.transproceed.2022.02.016

Year: 2022

SARS-CoV-2 cross-reactive B and T cell responses in kidney-transplant patients

DOI: 10.1016/j.transproceed.2022.02.016

Year: 2022

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis

DOI: 10.3390/vaccines10020327

Year: 2022

COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital

DOI: 10.3390/v14040746

Year: 2022

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination

DOI: 10.3389/fimmu.2022.816220

Year: 2022

The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients

DOI: 10.3389/fcimb.2022.848650

Year: 2022

Comment on Schäfer et al. “Impact of COVID-19 on Public Mental Health and the Buffering Effect of a Sense of Coherence”: High Level of COVID-19-Related Posttraumatic Stress in COVID-19 Survivors with Low Sense of Coherence

DOI: 10.1159/000520963

Year: 2022

Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets

DOI: 10.3389/fimmu.2022.818704

Year: 2022

Rapid Steroid Withdrawal after Renal Transplantation Reduces Mortality: Five Year Follow-Up of a Randomized Controlled Trial (Harmony Study) Confirms Long Term Efficacy and Safety

DOI: 10.2139/ssrn.3816528

Year: 2021

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

DOI: 10.1101/2021.07.21.21260624

Year: 2021

What Role Do Governments and Organizations Play?

What Certifications are Necessary?

What is the Global Impact of Dengue Hemorrhagic Fever?

What Topics are Covered During Training?

Which Diseases Spread Through Airborne Transmission?

How Can We Prevent Culex-Transmitted Diseases?

What is the Inflammatory Response?

Why is Genomic Sequencing Important for Infectious Diseases?

What are the Best Practices for Food Hygiene?

What is Rabies?

Partnered Content Networks

Relevant Topics